Racial differences in breast cancer stage at diagnosis in the mammography era

American Journal of Public Health

Volumn 103, Issue 1, 2013, Pages 170-176

  Chatterjee, Neal A ^a   He, Yulei ^b   Keating, Nancy L ^b,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; BREAST TUMOR; CANCER REGISTRY; CANCER STAGING; CAUCASIAN; COMPARATIVE STUDY; ETHNOLOGY; FEMALE; HUMAN; MAMMOGRAPHY; MIDDLE AGED; NEGRO; PATHOLOGY; RACE; RADIOGRAPHY; SOCIOECONOMICS; STATISTICS; SURVIVAL RATE; UNITED STATES; UTILIZATION REVIEW;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; BREAST NEOPLASMS; CONTINENTAL POPULATION GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; NEOPLASM STAGING; SEER PROGRAM; SOCIOECONOMIC FACTORS; SURVIVAL RATE; UNITED STATES;

EID: 84872542270     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2011.300550     Document Type: Article

References (59)

1. Kochanek KD, Murphy SL, Anderson RN, Scott C. Deaths: final data for 2002. Natl Vital Stat Rep. 2004;53 (5):1-115.
2. Jones BA, Patterson EA, Calvocoressi L. Mammography screening in African American women: evaluating the research. Cancer. 2003;97(suppl 1):258-272. (Pubitemid 36033848)
3. Tammemagi CM. Racial/ethnic disparities in breast and gynecologic cancer treatment and outcomes. Curr Opin Obstet Gynecol. 2007;19(1):31-36. (Pubitemid 46095870)
4. Rosenberg J, Chia YL, Plevritis S. The effect of age, race, tumor size, tumor grade, and disease stage on invasive ductal breast cancer survival in the U.S. SEER database. Breast Cancer Res Treat. 2005;89(1):47-54. (Pubitemid 40228446)
5. Li CI, Moe RE, Daling JR. Risk of mortality by histologic type of breast cancer among women aged 50 to 79 years. Arch Intern Med. 2003;163(18):2149-2153. (Pubitemid 37248779)
6. Sant M, Allemani C, Capocaccia R, et al. Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer. 2003;106 (3):416-422. (Pubitemid 36870406)
7. Bradley CJ, Given CW, Roberts C. Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst. 2002;94(7):490-496. (Pubitemid 34411287)
8. Clegg LX, Li FP, Hankey BF, Chu K, Edwards BK. Cancer survival among US Whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) Program population-based study. Arch Intern Med. 2002;162(17):1985-1993.
9. Moormeier J. Breast cancer in Black women. Ann Intern Med. 1996;124(10):897-905. (Pubitemid 26193308)
10. Sassi F, Luft HS, Guadagnoli E. Reducing racial/ethnic disparities in female breast cancer: screening rates and stage at diagnosis. Am J Public Health. 2006;96 (12):2165-2172. (Pubitemid 44865108)
11. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement [published correction appears in Ann Intern Med. 2010;152(3):199-200
12. Ann Intern Med. 2010;152(10):688.
13. Ann Intern Med. 2009;151(10):716-726, W-236.
14. Breen N, Wagener DK, Brown ML, Davis WW, Ballard-Barbash R. Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. J Natl Cancer Inst. 2001;93(22):1704-1713. (Pubitemid 33130259)
15. Breen N, Cronin KA, Meissner HI, et al. Reported drop in mammography: is this cause for concern? Cancer. 2007;109(12):2405-2409. (Pubitemid 46906458)
16. Jones AR, Caplan LS, Davis MK. Racial/ethnic differences in the self-reported use of screening mammography. J Community Health. 2003;28(5):303-316. (Pubitemid 38113241)
17. Adams EK, Florence CS, Thorpe KE, Becker ER, Joski PJ. Preventive care: female cancer screening, 1996-2000. Am J Prev Med. 2003;25(4):301-307. (Pubitemid 37346151)
18. Nelson HD, Tyne K, Naik A, et al. Screening for breast cancer: an update for the U. S. Preventive Services Task Force. Ann Intern Med. 2009;151(10):727-737, W237-742.
19. Gøtzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2011; (1):CD001877.
20. Shapiro S, Venet W, Strax P, Venet L, Roeser R. Prospects for eliminating racial differences in breast cancer survival rates. Am J Public Health. 1982;72 (10):1142-1145.
21. King ES, Rimer BK, Trock B, Balshem A, Engstrom P. How valid are mammography self-reports? Am J Public Health. 1990;80(11):1386-1388. (Pubitemid 20375565)
22. Surveillance, Epidemiology, and End Results (SEER) Program SEER Stat Database: Incidence-SEER 9 Regs Research Data. National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch. Available at: http://www.seer.cancer.gov. Accessed February 21, 2011.
23. US Department of Commerce, Economics and Statistics Adminstration, US Census Bureau. US Census, 2000. Available at: http://www.census.gov/main/www/ cen2000.html. Accessed February 21, 2011.
24. Small Area Health Insurance Estimates 2005 Public Use Database. US Department of Commerce, Economics and Statistics Administration, US Census Bureau. Available at: http://www.census.gov/did/www/sahie. Accessed February 21, 2011.
25. Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Survey Data. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2006. Available at: http://www.cdc.gov/brfss/technical-infodata/surveydata/2006.htm. Accessed February 21, 2011.
26. Etzi S, Lane DS, Grimson R. The use of mammography vans by low-income women: the accuracy of selfreports. Am J Public Health. 1994;84(1):107-109. (Pubitemid 24023522)
27. Zapka JG, Bigelow C, Hurley T, et al. Mammography use among sociodemographically diverse women: the accuracy of self-report. Am J Public Health. 1996;86 (7):1016-1021. (Pubitemid 26242952)
28. Surveillance, Epidemiology, and End Results (SEER) Program. SEER staging. Available at: http://seer. cancer.gov/seerstat/variables/seer/yr1973-2007/lrd- stage. Accessed February 21, 2011.
29. Lantz PM, Mujahid M, Schwartz K, et al. The influence of race, ethnicity, and individual socioeconomic factors on breast cancer stage at diagnosis. Am J Public Health. 2006;96(12):2173-2178. (Pubitemid 44865109)
30. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335-351. (Pubitemid 30070608)
31. Howe HL, Wu X, Ries LA, et al. Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer. 2006;107(8):1711-1742. (Pubitemid 44582941)
32. Glass AG, Lacey JV Jr, Carreon JD, Hoover RN. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst. 2007;99(15):1152-1161. (Pubitemid 47233065)
33. Little RJA. Direct standardization: a tool for teaching linear models for unbalanced data. Am Stat. 1982;36 (1):38-43.
34. Rakowski W, Clark MA, Rogers ML, Weitzen S. Investigating reversals of association for utilization of recent mammography among Hispanic and non-Hispanic Black women. Cancer Causes Control. 2009;20(8):1483-1495.
35. Chagpar AB, Polk HC Jr, McMasters KM. Racial trends in mammography rates: a population-based study. Surgery. 2008;144(3):467-472.
36. Gill KS, Yankaskas BC. Screening mammography performance and cancer detection among Black women and White women in community practice. Cancer. 2004;100(1):139-148. (Pubitemid 37553549)
37. Hahn KM, Bondy ML, Selvan M, et al. Factors associated with advanced disease stage at diagnosis in a population-based study of patients with newly diagnosed breast cancer. Am J Epidemiol. 2007;166(9):1035-1044. (Pubitemid 47574681)
38. Lannin DR, Mathews HF, Mitchell J, Swanson MS, Swanson FH, Edwards MS. Influence of socioeconomic and cultural factors on racial differences in late-stage presentation of breast cancer. JAMA. 1998;279 (22):1801-1807. (Pubitemid 28280252)
39. Moorman PG, Jones BA, Millikan RC, Hall IJ, Newman B. Race, anthropometric factors, and stage at diagnosis of breast cancer. Am J Epidemiol. 2001;153 (3):284-291. (Pubitemid 32958653)
40. Jacobellis J, Cutter G. Mammography screening and differences in stage of disease by race/ethnicity. Am J Public Health. 2002;92(7):1144-1150. (Pubitemid 34700982)
41. Jemal A, Ward E, Thun MJ. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women. Breast Cancer Res. 2007;9(3):R28.
42. Li CI, Daling JR. Changes in breast cancer incidence rates in the United States by histologic subtype and race/ethnicity, 1995 to 2004. Cancer Epidemiol Biomarkers Prev. 2007;16(12):2773-2780. (Pubitemid 351196336)
43. Esserman L, Shieh Y, Thompson I. Rethinking screening for breast cancer and prostate cancer. JAMA. 2009;302(15):1685-1692.
44. Ikeda DM, Andersson I, Wattsgard C, Janzon L, Linell F. Interval carcinomas in the Malmo Mammographic Screening Trial: radiographic appearance and prognostic considerations. AJR Am J Roentgenol. 1992; 159(2):287-294.
45. Baines CJ, Vidmar M, McKeown-Eyssen G, Tibshirani R. Impact of menstrual phase on false-negative mammograms in the Canadian National Breast Screening Study. Cancer. 1997;80(4):720-724. (Pubitemid 27339827)
46. White E, Miglioretti DL, Yankaskas BC, et al. Biennial versus annual mammography and the risk of late-stage breast cancer. J Natl Cancer Inst. 2004;96(24): 1832-1839. (Pubitemid 40081320)
47. Biesheuvel C, Barratt A, Howard K, Houssami N, Irwig L. Effects of study methods and biases on estimates of invasive breast cancer overdetection with mammography screening: a systematic review. Lancet Oncol. 2007;8(12):1129-1138. (Pubitemid 350182969)
48. Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst. 2010;102(9):605-613.
49. Ravdin PM, Cronin KA, Howlader N, et al. The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med. 2007;356(16):1670-1674. (Pubitemid 46631679)
50. Brett KM, Madans JH. Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study. Am J Epidemiol. 1997;145(6):536-545. (Pubitemid 27111222)
51. Wei F, Miglioretti DL, Connelly MT, et al. Changes in women's use of hormones after the Women's Health Initiative estrogen and progestin trial by race, education, and income. J Natl Cancer Inst Monogr. 2005;(35):106-112.
52. Clarke CA, Glaser SL, Uratsu CS, Selby JV, Kushi LH, Herrinton LJ. Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence. J Clin Oncol. 2006;24(33): e49-e50.
53. Hersh AL, Stefanick ML, Stafford RS. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA. 2004;291(1): 47-53. (Pubitemid 38040534)
54. Adams SA, Smith ER, Hardin J, Prabhu-Das I, Fulton J, Hebert JR. Racial differences in follow-up of abnormal mammography findings among economically disadvantaged women. Cancer. 2009;115(24):5788-5797.
55. Jones BA, Kasl SV, CurnenMG, Owens PH, Dubrow R. Can mammography screening explain the race difference in stage at diagnosis of breast cancer? Cancer. 1995; 75(8):2103-2113.
56. McCarthy EP, Burns RB, Coughlin SS, et al. Mammography use helps to explain differences in breast cancer stage at diagnosis between older Black and White women. Ann Intern Med. 1998;128(9):729-736. (Pubitemid 28204864)
57. Smith-Bindman R, Miglioretti DL, Lurie N, et al. Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med. 2006;144(8):541-553. (Pubitemid 46768143)
58. Royak-Schaler R, Rose DP. Mammography screening and breast cancer biology in African American women-a review. Cancer Detect Prev. 2002;26(3):180-191. (Pubitemid 36035387)
59. Altekruse S, Kosary C, Krapcho M, et al. SEER cancer statistics review, 1975-2007. National Cancer Institute. 2010. Available at: http://seer.cancer. gov/csr/1975-2007. Accessed February 21, 2011.